Biomarkers for prenatal diagnosis of congenital cytomegalovirus

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/70 (2006.01) C12Q 1/68 (2006.01) G01N 33/569 (2006.01)

Patent

CA 2703165

The invention provides compositions and methods useful for early detection of congenital CMV infection, predicting the likelihood and severity of congenital CMV disease, and monitoring the efficacy of therapeutic approaches. Compositions of the present invention include biomarkers that are differentially expressed in CMV- infected mothers and fetuses compared to uninfected individuals.

L'invention propose des compositions et des procédés utiles pour une détection précoce d'infections à CMV congénital, prévoyant la probabilité et l'importance d'un CMV congénital et surveillant l'efficacité des approches thérapeutiques. Des compositions de l'invention comprennent des biomarqueurs qui sont exprimés différemment chez des mères et des ftus affectés par le CMV, par comparaison à des individus non affectés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers for prenatal diagnosis of congenital cytomegalovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for prenatal diagnosis of congenital cytomegalovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for prenatal diagnosis of congenital cytomegalovirus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1573417

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.